Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy [PDF]
PURPOSE: To investigate whether caffeic acid phenethyl ester (CAPE) and cortisone prevent proliferative vitreoretinopathy (PVR).
Yusuf Turkoz+6 more
doaj +2 more sources
A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques [PDF]
Rhegmatogenous retinal detachment (RRD) requires surgical intervention for its repair. There are variable techniques used for this purpose, and they are all being continuously refined.
Achia Nemet+4 more
doaj +4 more sources
The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy [PDF]
This is an open-access article distributed under the terms of the Creative Commons Attribution License.-- et al.Proliferative vitreoretinopathy (PVR) is still the major cause of failure in retinal detachment (RD) surgery.
González-Sarmiento, Rogelio+3 more
core +3 more sources
Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy [PDF]
Background Platelet-derived growth factor receptor β (PDGFRβ) is the principal PDGFR isoform in retinal pigment epithelial (RPE) cells from the epiretinal membranes of patients with proliferative vitreoretinopathy (PVR).
Duo Li+8 more
doaj +2 more sources
Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice [PDF]
Proliferative vitreoretinopathy is a vision-threatening response to penetrating ocular injury, for which there is no satisfactory treatment. In this disorder, retinal pigment epithelial cells, abandon their attachment to Bruch’s membrane on the scleral ...
Min Luo+7 more
doaj +2 more sources
p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model. [PDF]
PurposeProliferative vitreoretinopathy (PVR) is a disease process resulting from proliferation of retinal pigment epithelial (RPE) cells in the vitreous and periretinal area, leading to periretinal membrane formation and traction and eventually to ...
Qi Zhang+7 more
doaj +3 more sources
Proliferative vitreoretinopathy: an update on the current and emerging treatment options. [PDF]
Proliferative vitreoretinopathy (PVR) remains the main cause of failure in retinal detachment (RD) surgery and a demanding challenge for vitreoretinal surgeons.
Ferro Desideri L+4 more
europepmc +3 more sources
Endoscopy-assisted pars plana vitrectomy in retinal detachments associated with anterior proliferative vitreoretinopathy and epiciliary membranes [PDF]
Background Proliferative vitreoretinopathy (PVR) is the leading cause of recurrent retinal detachment. Anterior PVR can contribute to recurrent retinal detachment and is often difficult to remove during conventional pars plana vitrectomy.
Radwan S. Ajlan+3 more
doaj +2 more sources
Proliferative vitreoretinopathy and its relationship with inflammatory serum biomarkers [PDF]
AIM: To analyze if a relationship between levels of inflammatory serum biomarkers and severity of primary proliferative vitreoretinopathy (PVR) exists. METHODS: A retrospective case-control study.
Victor Alejandro Martinez Pacheco+3 more
doaj +2 more sources
Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trial [PDF]
In this randomized controlled trial, we assessed the effects of three consecutive intra-silicone oil (SO) injections of methotrexate (MTX) on the outcomes of surgery for proliferative vitreoretinopathy grade C (PVR-C).
Ramin Nourinia+30 more
doaj +2 more sources